DBV Technologies (DBVT) Change in Intangibles (2016 - 2020)
DBV Technologies (DBVT) reported Change in Intangibles of $9000.0 for Q4 2020, little changed on a QoQ basis from $9000.0 in Q3 2020.
DBV Technologies (DBVT) has 5 years of Change in Intangibles data on file, last reported at $9000.0 in Q4 2020.
- Quarterly Change in Intangibles changed N/A year-over-year to $9000.0 in Q4 2020, while the trailing twelve-month figure through Mar 2025 was $9000.0 (changed N/A YoY) and the FY2025 annual result came in at $6000.0, up 100.0% from the prior year.
- Change in Intangibles held at $9000.0 in Q4 2020 per DBVT's latest filing, from $9000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $114000.0 in Q1 2020 and bottomed at -$352052.3 in Q4 2017.
- The 5-year median for Change in Intangibles is -$33050.4 (2018), against an average of -$68002.5.
- The widest annual swing landed in 2017, when Change in Intangibles plunged 51.65%; it then surged 129.96% in 2020.
- Tracing DBVT's Change in Intangibles over 5 years: stood at -$232140.7 in 2016, then slumped by 51.65% to -$352052.3 in 2017, then soared by 86.71% to -$46797.3 in 2018, then surged by 35.8% to -$30043.7 in 2019, then surged by 129.96% to $9000.0 in 2020.
- Per Business Quant, the three latest DBVT Change in Intangibles figures stand at $9000.0 (Q4 2020), $9000.0 (Q3 2020), and -$103000.0 (Q2 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | -103,000.00 |
| Jun 30, 2020 | -103,000.00 |
| Mar 31, 2020 | 114,000.00 |
| Mar 31, 2020 | 114,000.00 |
| Sep 30, 2019 | -30,043.71 |
| Sep 30, 2019 | -30,043.71 |
| Dec 31, 2018 | -46,797.25 |
| Dec 31, 2018 | -46,797.25 |
| Sep 30, 2018 | -36,057.00 |
| Sep 30, 2018 | -36,057.00 |
| Jun 30, 2018 | -11,934.44 |
| Jun 30, 2018 | -11,934.44 |
| Dec 31, 2017 | -352,052.32 |
| Dec 31, 2017 | -352,052.32 |
| Dec 31, 2016 | -232,140.71 |
| Dec 31, 2016 | -232,140.71 |